There are currently no approved disease-modifying osteoarthritis drugs (DMOADs) and only symptom relief treatments are available.
Watch Yi He present how our biomarkers have the potential to aid Osteoarthritis drug development in various stages.
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.